|
US101A
(en)
|
|
1836-12-06 |
|
Method of jcakibtg and furling iw sails fob ships |
|
US5530A
(en)
|
|
1848-04-25 |
|
Horse-power |
|
US5208036A
(en)
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
EP0656946B2
(en)
|
1992-08-21 |
2010-03-31 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
DE69318420T2
(de)
|
1992-12-14 |
1999-01-28 |
Naamloze Vennootschap Innogenetics S.A., Gent |
Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung
|
|
EP0735893B1
(en)
|
1993-09-14 |
2008-11-26 |
Pharmexa Inc. |
Pan dr-binding peptides for enhancement of the immune response
|
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
DE19539493A1
(de)
|
1995-10-24 |
1997-04-30 |
Thomae Gmbh Dr K |
Starker homologer Promotor aus Hamster
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
EP1005368B1
(en)
|
1997-03-10 |
2009-09-02 |
Ottawa Hospital Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants
|
|
US5888809A
(en)
|
1997-05-01 |
1999-03-30 |
Icos Corporation |
Hamster EF-1α transcriptional regulatory DNA
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
CA2361492A1
(en)
|
1999-02-05 |
2000-08-10 |
Samsung Electronics Co., Ltd. |
Image texture retrieving method and apparatus thereof
|
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
|
WO2004006955A1
(en)
|
2001-07-12 |
2004-01-22 |
Jefferson Foote |
Super humanized antibodies
|
|
JP4393382B2
(ja)
|
2002-08-14 |
2010-01-06 |
三菱化学株式会社 |
中枢性タウ蛋白質特異的抗体
|
|
MXPA05005481A
(es)
|
2002-11-29 |
2005-07-25 |
Boehringer Ingelheim Pharma |
Nuevos genes de la fosfotransferasa de neomicina y procedimiento para la seleccion de celulas recombinantes de produccion elevada.
|
|
US7847146B2
(en)
|
2003-03-28 |
2010-12-07 |
Baylor College Of Medicine |
Model for neurodegenerative disorders
|
|
DE10338531A1
(de)
|
2003-08-19 |
2005-04-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Reklonierung von Produktionszellen
|
|
US20050132424A1
(en)
|
2003-10-21 |
2005-06-16 |
Envivo Pharmaceuticals, Inc. |
Transgenic flies expressing Abeta42-Dutch
|
|
US7910100B2
(en)
|
2004-10-01 |
2011-03-22 |
Max-Planck-Gesellschaft zur Forderung der Wissen |
Antibodies directed to the mammalian EAG1 ion channel protein
|
|
PT1820022E
(pt)
|
2004-11-10 |
2009-08-05 |
Boehringer Ingelheim Pharma |
Utilização de análise por citometria de fluxo para optimizar estratégias de conservação de bancos de células cho
|
|
AU2005318171B2
(en)
|
2004-12-20 |
2011-09-29 |
Crucell Holland B.V. |
Binding molecules capable of neutralizing West Nile virus and uses thereof
|
|
ATE500276T1
(de)
|
2004-12-30 |
2011-03-15 |
Us Gov Health & Human Serv |
Humanisierte col-1-antikörper mit substituierten resten am gerüst, und deren anwendung
|
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
WO2007149293A2
(en)
|
2006-06-16 |
2007-12-27 |
Envivo Pharmaceutical, Inc. |
Transgenic flies expressing tau and amyloid precursor fragment
|
|
WO2007147213A1
(en)
|
2006-06-22 |
2007-12-27 |
Walter And Eliza Hall Institute Of Medical Research |
Structure of the insulin receptor ectodomain
|
|
US20080124760A1
(en)
|
2006-07-26 |
2008-05-29 |
Barbara Enenkel |
Regulatory Nucleic Acid Elements
|
|
US20100216703A1
(en)
|
2006-08-14 |
2010-08-26 |
The Regents Of The University Of California |
Inhibitors of PDE4 and Methods of Use
|
|
CN103172743B
(zh)
|
2006-12-01 |
2015-04-08 |
梅达雷克斯有限责任公司 |
结合cd22的人抗体及其用途
|
|
DK3067066T3
(da)
|
2007-02-23 |
2019-05-20 |
Prothena Biosciences Ltd |
Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
|
|
WO2008107388A1
(en)
|
2007-03-02 |
2008-09-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Improvement of protein production
|
|
EP2031064A1
(de)
|
2007-08-29 |
2009-03-04 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verfahren zur Steigerung von Proteintitern
|
|
JP2009056790A
(ja)
|
2007-09-03 |
2009-03-19 |
Takao Otogawa |
ファイル用ポケット
|
|
BRPI0817255A2
(pt)
|
2007-09-26 |
2017-06-06 |
Amgen Inc |
proteínas de ligação a antígeno de fator de crescimento tipo fator de crescimento epidermal de ligação à heparina.
|
|
US9272030B2
(en)
|
2007-10-17 |
2016-03-01 |
Janssen Sciences Ireland Uc |
Use of tau to monitor immunotherapy
|
|
CA2705292C
(en)
|
2007-11-13 |
2016-06-21 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against tl1a
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
JP2010014691A
(ja)
|
2008-06-20 |
2010-01-21 |
Igaku Seibutsugaku Kenkyusho:Kk |
腹水中のメソテリン及び／又は巨核球増強因子を検出するための方法、キット、試薬及び装置
|
|
NZ591471A
(en)
|
2008-08-18 |
2012-08-31 |
Pfizer |
Antibodies to ccr2
|
|
US9605054B2
(en)
|
2009-02-23 |
2017-03-28 |
The Board Of Trustees Of The University Of Illinois |
Composition and method for treating a tauopathy
|
|
KR20160005143A
(ko)
|
2009-05-13 |
2016-01-13 |
젠자임 코포레이션 |
항-인간 ｃｄ52 면역글루불린
|
|
EP4218794A3
(en)
|
2009-06-10 |
2023-09-13 |
New York University |
Immunological targeting of pathological tau proteins
|
|
US20110045534A1
(en)
|
2009-08-20 |
2011-02-24 |
Cell Signaling Technology, Inc. |
Nucleic Acid Cassette For Producing Recombinant Antibodies
|
|
WO2011026031A1
(en)
|
2009-08-28 |
2011-03-03 |
The Board Of Regents Of The University Of Texas System |
Antibodies that bind tau oligomers
|
|
WO2011053565A2
(en)
|
2009-10-29 |
2011-05-05 |
Biomedical Sciences Research Centre "Alexander Fleming" |
Compositions and methods for detecting a tauopathy
|
|
JP2013514992A
(ja)
|
2009-12-18 |
2013-05-02 |
アムジェン インコーポレイテッド |
Ｗｉｓｅ結合剤およびエピトープ
|
|
CN102711812B
(zh)
|
2010-01-08 |
2014-07-16 |
国立大学法人京都大学 |
Tau蛋白病治疗用疫苗
|
|
MX2012009215A
(es)
|
2010-02-23 |
2012-11-23 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores.
|
|
JP2011201655A
(ja)
|
2010-03-25 |
2011-10-13 |
Minoru Industrial Co Ltd |
ダンボールテープ貼付機
|
|
EP2558494B1
(en)
|
2010-04-15 |
2018-05-23 |
AbbVie Inc. |
Amyloid-beta binding proteins
|
|
ITRM20100320A1
(it)
|
2010-06-11 |
2011-12-11 |
Consiglio Nazionale Ricerche |
Metodo per la diagnostica e il trattamento delle taupatie
|
|
US20120023911A1
(en)
|
2010-07-28 |
2012-02-02 |
Gm Global Technology Operations, Inc. |
Detection of exhaust particulate filter substrate failure
|
|
LT2627672T
(lt)
|
2010-10-11 |
2018-12-10 |
Biogen International Neuroscience Gmbh |
Žmogaus antikūnai prieš tau baltymą
|
|
JP2014511174A
(ja)
|
2011-02-07 |
2014-05-15 |
ネオトープ バイオサイエンシーズ リミテッド |
Ａｐｏｅ免疫療法
|
|
EP2701743A4
(en)
|
2011-04-27 |
2015-08-19 |
Univ Northwestern |
FOR PATHOLOGICAL TAU-DIMERE AND PREAFIBRILLARY PATHOLOGICAL TAU-OLIGOMER SELECTIVE ANTIBODIES AND THEIR USES IN THE APPLICATION, DIAGNOSIS AND MONITORING OF TAUOPATHIES
|
|
GB201109238D0
(en)
|
2011-06-01 |
2011-07-13 |
Antitope Ltd |
Antibodies
|
|
GB201111361D0
(en)
|
2011-07-04 |
2011-08-17 |
Nordic Bioscience As |
Biochemical markers for neurodegenerative conditions
|
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
CA2845884A1
(en)
|
2011-08-22 |
2013-02-28 |
Cangene Corporation |
Clostridium difficile antibodies
|
|
SMT201800109T1
(it)
|
2011-09-19 |
2018-05-02 |
Axon Neuroscience Se |
Terapia a base di proteine e diagnosi di una patologia mediata da tau nella malattia di alzheimer
|
|
TW201326209A
(zh)
|
2011-09-30 |
2013-07-01 |
Chugai Pharmaceutical Co Ltd |
具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
|
|
JP6358953B2
(ja)
|
2011-10-07 |
2018-07-18 |
エーシー イミューン エス．エー． |
タウを認識するホスホ特異的抗体
|
|
WO2013059786A1
(en)
|
2011-10-21 |
2013-04-25 |
The Ohio State University |
Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease
|
|
LT2831113T
(lt)
|
2012-03-28 |
2018-06-25 |
Sanofi |
Antikūnai prieš bradikinino b1 receptoriaus ligandus
|
|
RU2644242C2
(ru)
|
2012-04-05 |
2018-02-08 |
Ац Иммуне С.А. |
Гуманизированное тау-антитело
|
|
CA2868327A1
(en)
|
2012-04-18 |
2013-10-24 |
E. I. Du Pont De Nemours And Company |
Multilayered sheet
|
|
DE102012211455A1
(de)
|
2012-07-02 |
2014-01-02 |
Wobben Properties Gmbh |
Handhabungsvorrichtung zum Handhaben einer Rotorblattform zum Fertigen eines Rotorblattes einer Windenergieanlage
|
|
WO2014008404A1
(en)
|
2012-07-03 |
2014-01-09 |
Washington University |
Antibodies to tau
|
|
JP6290212B2
(ja)
|
2012-08-16 |
2018-03-07 |
アイピエリアン，インコーポレイティド |
タウオパチーの処置方法
|
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
|
WO2014059442A2
(en)
|
2012-10-12 |
2014-04-17 |
Arizona Board Agents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
|
US9200068B2
(en)
|
2012-12-18 |
2015-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods related to tauopathy
|
|
JP6284548B2
(ja)
|
2012-12-21 |
2018-02-28 |
バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． |
ヒト抗タウ抗体
|
|
US8980270B2
(en)
|
2013-01-18 |
2015-03-17 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
US9364191B2
(en)
|
2013-02-11 |
2016-06-14 |
University Of Rochester |
Method and apparatus of spectral differential phase-contrast cone-beam CT and hybrid cone-beam CT
|
|
JP6674888B2
(ja)
|
2013-03-13 |
2020-04-01 |
プロセナ バイオサイエンシーズ リミテッド |
タウ免疫療法
|
|
US9688747B2
(en)
|
2013-03-15 |
2017-06-27 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
EP3418430B1
(en)
|
2013-03-15 |
2023-03-29 |
The Trustees of the University of Pennsylvania |
Blood biomarkers that predict persistent cognitive dysfunction after concussion
|
|
CN105658672A
(zh)
|
2013-08-22 |
2016-06-08 |
阿塞勒隆制药公司 |
TGF-β受体II型变体及其用途
|
|
JP6629201B2
(ja)
|
2013-11-27 |
2020-01-15 |
アイピエリアン，インコーポレイティド |
タウオパチーの処置方法
|
|
JP2017505756A
(ja)
|
2013-12-13 |
2017-02-23 |
ザ ジェネラル ホスピタル コーポレイション |
可溶性高分子量（ｈｍｗ）タウ種およびその用途
|
|
KR102357961B1
(ko)
|
2013-12-17 |
2022-02-08 |
제넨테크, 인크. |
항-cd3 항체 및 이의 사용 방법
|
|
US9629801B2
(en)
|
2014-01-10 |
2017-04-25 |
Wisconsin Alumni Research Foundation |
Blood-brain barrier targeting antibodies
|
|
US20150253341A1
(en)
|
2014-02-10 |
2015-09-10 |
Merck Sharp & Dohme Corp. |
Quantification of tau in biological samples by immunoaffinity enrichment and mass spectrometry
|
|
CA2952745A1
(en)
|
2014-06-26 |
2015-12-30 |
Janssen Vaccines & Prevention B.V. |
Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
|
|
TW202136296A
(zh)
|
2014-06-27 |
2021-10-01 |
美商Ｃ２Ｎ醫療診斷有限責任公司 |
人類化抗-tau抗體
|
|
PT3221349T
(pt)
|
2014-11-19 |
2021-01-21 |
Axon Neuroscience Se |
Anticorpos tau humanizados na doença de alzheimer
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016137950A1
(en)
|
2015-02-24 |
2016-09-01 |
Rpeptide, Llc |
Anti-tau antibodies
|
|
EP3303386B1
(en)
|
2015-06-05 |
2024-08-28 |
Genentech, Inc. |
Anti-tau antibodies and methods of use
|
|
US20200030445A1
(en)
|
2015-06-12 |
2020-01-30 |
C2N Diagnostics, Llc |
Stable formulations of humanized anti-tau antibody
|
|
CN107849105B
(zh)
|
2015-07-06 |
2021-09-17 |
Ucb生物制药有限责任公司 |
Tau结合抗体
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
US11327080B2
(en)
|
2015-07-21 |
2022-05-10 |
BioArctic Neruoscience AB |
Method for treatment of traumatic brain injury targeting aggregated peptides
|
|
JP7725185B2
(ja)
|
2015-10-06 |
2025-08-19 |
アレクトル エルエルシー |
抗ｔｒｅｍ２抗体及びその使用方法
|
|
PL3452507T3
(pl)
|
2016-05-02 |
2023-01-09 |
Prothena Biosciences Limited |
Immunoterapia tau
|
|
EP3452509A1
(en)
|
2016-05-02 |
2019-03-13 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
CN109219615B
(zh)
|
2016-05-02 |
2022-12-09 |
普罗塞纳生物科学有限公司 |
识别tau的抗体
|
|
WO2018085653A1
(en)
|
2016-11-04 |
2018-05-11 |
The Regents Of The University Of California |
Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them
|
|
CN110248959B
(zh)
|
2016-12-07 |
2023-06-30 |
基因泰克公司 |
抗tau抗体和使用方法
|
|
AU2017373889B2
(en)
|
2016-12-07 |
2025-01-02 |
Ac Immune Sa |
Anti-Tau antibodies and methods of use
|
|
KR20190134997A
(ko)
|
2017-02-17 |
2019-12-05 |
데날리 테라퓨틱스 인크. |
항-tau 항체 및 이의 사용 방법
|
|
WO2018156250A1
(en)
|
2017-02-21 |
2018-08-30 |
Remd Biotherapeutics, Inc. |
Cancer treatment using antibodies that bind cytotoxic t-lymphocyte antigen-4 (ctla-4)
|
|
JOP20180021A1
(ar)
|
2017-03-16 |
2019-01-30 |
Janssen Biotech Inc |
الأجسام المضادة لتكتلات خيوط بروتين تاو (tau) الحلزونية المزدوجة واستخداماتها
|
|
CA3055758A1
(en)
|
2017-03-28 |
2018-10-04 |
Genentech, Inc. |
Methods of treating neurodegenerative diseases
|
|
CN110418804A
(zh)
|
2017-03-28 |
2019-11-05 |
扬森疫苗与预防公司 |
与tau特异性地结合的结合分子
|
|
CN110881274B
(zh)
|
2017-05-02 |
2024-11-15 |
普罗塞纳生物科学有限公司 |
识别tau的抗体
|
|
CN110770253A
(zh)
|
2017-06-16 |
2020-02-07 |
百时美施贵宝公司 |
用于治疗tau蛋白病的组合物和方法
|
|
TWI750419B
(zh)
|
2017-10-16 |
2021-12-21 |
日商衛材R&D企管股份有限公司 |
抗tau抗體及其用途
|
|
AU2018364630A1
(en)
|
2017-11-09 |
2020-05-21 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
|
SG11202004904XA
(en)
|
2017-12-04 |
2020-06-29 |
Janssen Vaccines & Prevention Bv |
Binding molecules that specifically bind to tau
|
|
CA3094934A1
(en)
|
2018-03-23 |
2019-09-26 |
AbbVie Deutschland GmbH & Co. KG |
Stable aqueous anti-tau antibody formulations
|
|
MX2020009991A
(es)
|
2018-03-28 |
2020-10-14 |
Axon Neuroscience Se |
Metodos basados en anticuerpos para detectar y tratar la enfermedad de alzheimer.
|
|
EP3784274A1
(en)
|
2018-04-27 |
2021-03-03 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
|
WO2020097561A1
(en)
|
2018-11-08 |
2020-05-14 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
WO2020096608A1
(en)
|
2018-11-08 |
2020-05-14 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
WO2020106598A1
(en)
|
2018-11-19 |
2020-05-28 |
The Board Of Regents Of The University Of Texas System |
Tau peptide antigens and antibodies binding thereto for the treatment of tauopathies
|
|
JP7681316B2
(ja)
|
2019-02-08 |
2025-05-22 |
プロセナ バイオサイエンシーズ リミテッド |
タウを認識する抗体
|
|
FR3092834B1
(fr)
|
2019-02-15 |
2021-09-24 |
Biorengaz |
Support de culture pour procédé méthanisation
|
|
AU2020231366A1
(en)
|
2019-03-03 |
2021-08-12 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
EP3947446A1
(en)
|
2019-03-25 |
2022-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of taupathy disorders by targeting new tau species
|
|
CN114430744B
(zh)
|
2019-07-15 |
2024-06-21 |
阿德尔公司 |
抗Tau抗体及其用途
|